We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




DNA-Based Platform Detects Traces of Molecules from Broad Range of Sources

By LabMedica International staff writers
Posted on 19 Jul 2016
Researchers have harnessed synthetic DNA technology to develop a super-efficient nanomachine that detects trace amounts of substances that range from viruses and bacteria to cocaine and metals.

"It's a completely new platform that can be adapted to many kinds of uses," said co-author John Brennan, director of Biointerfaces Insitute, McMaster University (Hamilton, Ontario, Canada), "These DNA nano-architectures are adaptable, so that any target should be detectable." Besides being life’s genetic material, DNA is also a very programmable molecule that lends itself to engineering for synthetic applications. More...
The new method shapes separately programmed pieces of DNA material into pairs of interlocking circles. The first remains inactive until it is released by the second, like a bicycle wheel in a lock. When the second circle, acting as the lock, is exposed to even a trace of the target substance, it opens, freeing the first circle of DNA, which replicates quickly and creates a signal, such as a color change.

"The key is that it's selectively triggered by whatever we want to detect," said Prof. Brennan, "We have essentially taken a piece of DNA and forced it to do something it was never designed to do. We can design the lock to be specific to a certain key. All the parts are made of DNA, and ultimately that key is defined by how we build it."

The idea came from nature itself, explained co-author Yingfu Li, who holds the Canada Research Chair in Nucleic Acids Research, "Biology uses all kinds of nanoscale molecular machines to achieve important functions in cells," said Prof. Li, "For the first time, we have designed a DNA-based nanomachine that is capable of achieving ultra-sensitive detection of a bacterial pathogen." The DNA-based nanomachine is being further developed into a user-friendly detection kit that will enable rapid testing of a variety of substances, and could move to clinical testing within a year.

The study, by Liu M et al, was published June 23, 2016, in the journal Nature Communications.

Related Links:
McMaster University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Urine Analyzer
respons® UDS100
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.